The G protein-coupled estrogen receptor GPER/GPR30 as a regulator of cardiovascular function
- 5 July 2011
- journal article
- review article
- Published by Elsevier BV in Vascular Pharmacology
- Vol. 55 (1-3), 17-25
- https://doi.org/10.1016/j.vph.2011.06.003
Abstract
No abstract availableKeywords
This publication has 124 references indexed in Scilit:
- Benzothiophene Selective Estrogen Receptor Modulators Provide Neuroprotection by a Novel GPR30-Dependent MechanismACS Chemical Neuroscience, 2011
- Selectively targeting estrogen receptors for cancer treatmentAdvanced Drug Delivery Reviews, 2010
- Estrogen Receptor Activation and Cardioprotection in Ischemia Reperfusion InjuryTrends in Cardiovascular Medicine, 2010
- Non-genomic regulation of vascular cell function and growth by estrogenMolecular and Cellular Endocrinology, 2009
- Signaling, physiological functions and clinical relevance of the G protein-coupled estrogen receptor GPERProstaglandins & Other Lipid Mediators, 2009
- In vivo effects of a GPR30 antagonistNature Chemical Biology, 2009
- Therapeutic concentrations of raloxifene augment nitric oxide-dependent coronary artery dilatation in vitroBritish Journal of Pharmacology, 2007
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980